A sub-analysis of the SUNRISE 1 trial of lemborexant in insomnia with mild obstructive sleep apnea скачать в хорошем качестве

A sub-analysis of the SUNRISE 1 trial of lemborexant in insomnia with mild obstructive sleep apnea

Margaret Moline, PhD, Eisai Inc., Nutley, NJ, comments on findings from the SUNRISE 1 study (NCT02783729), evaluating the efficacy and safety of lemborexant in treating insomnia disorder in a subset of older adults with mild obstructive sleep apnea. Dr Moline highlights that lemborexant improved sleep onset and duration, and also enhanced alertness. This sub-analysis provides valuable insights into the benefits of lemborexant in older adults with insomnia disorder and mild obstructive sleep apnea. This interview took place at the 77th American Academy of Neurology (AAN) Annual Meeting in San Diego, CA. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.